av/royalty-pharma--big.svg

COM:ROYALTYPHARMA

Royalty Pharma

  • Stock

Last Close

26.22

21/11 21:00

Market Cap

11.73B

Beta: -

Volume Today

3.03M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.16
-
0.15
7.69%
0.10
30.98%
0.13
29.95%
0.13
1.80%
0.14
8.02%
cash conversion cycle
79.91
-
2.68K
-
-78.31
102.92%
-502.97
542.26%
cash per share
6.74
-
2.24
66.76%
5.31
136.90%
6.76
27.38%
5.54
17.98%
0.82
85.18%
company equity multiplier
2.53
-
2.04
19.51%
2.13
4.55%
3.03
42.23%
2.99
1.48%
2.51
15.98%
days of inventory outstanding
51.53
-
2.72K
-
days of payables outstanding
12.02
-
44.64
-
89.20
99.85%
508.94
470.54%
days of sales outstanding
40.39
-
7.80
80.69%
6.74
13.62%
10.89
61.65%
5.97
45.17%
120.15
1,912.35%
dividend yield
0.05
-
0.05
10.77%
0.05
9.22%
0.02
54.96%
0.02
18.34%
0.02
11.62%
0.02
9.87%
ebit per revenue
0.59
-
0.76
29.27%
1.45
90.20%
0.75
48.01%
0.62
16.86%
0.44
30.08%
0.63
45.04%
ebt per ebit
1.43
-
1.11
22.17%
0.94
15.65%
1.07
13.72%
0.87
18.70%
0.24
72.87%
1.14
384.09%
effective tax rate
0.40
-
0.29
29.33%
0.14
50.29%
0.67
374.84%
0.61
8.85%
0.81
32.48%
0.33
59.15%
enterprise value multiple
14.40
-
8.23
42.82%
12.54
52.29%
14.90
18.84%
23.10
55.04%
15.14
34.46%
fixed asset turnover
free cash flow per share
4.00
-
5.33
33.11%
4.71
11.69%
11.27
139.43%
4.87
56.83%
9.56
96.41%
1.52
84.10%
gross profit margin
1
-
0.92
7.57%
1
8.20%
0.96
4.15%
0.99
3.28%
1.00
0.76%
1
0.25%
interest coverage
3.80
-
4.87
28.28%
9.77
100.40%
10.16
4.01%
8.61
15.24%
5.20
39.61%
7.97
53.28%
inventory turnover
7.08
-
0.13
-
long term debt to capitalization
0.58
-
0.49
15.09%
0.37
25.03%
0.55
48.91%
0.52
5.51%
0.48
6.98%
net income per ebt
0.90
-
0.91
0.76%
0.95
5.12%
0.33
65.82%
0.39
18.29%
0.19
51.73%
0.67
258.54%
net profit margin
0.76
-
0.77
1.37%
1.29
68.65%
0.26
79.80%
0.21
20.05%
0.02
90.84%
0.48
2,417.46%
operating cash flow per share
4.00
-
4.57
14.10%
4.71
3.02%
5.42
15.12%
4.86
10.25%
4.90
0.65%
5.03
2.72%
operating cycle
91.93
-
2.73K
-
10.89
99.60%
5.97
45.17%
operating profit margin
0.59
-
0.76
29.27%
1.45
90.20%
0.75
48.01%
0.62
16.86%
0.44
30.08%
0.63
45.04%
payables turnover
30.37
-
8.18
-
4.09
49.96%
0.72
82.47%
pretax profit margin
0.84
-
0.85
0.60%
1.36
60.43%
0.80
40.88%
0.54
32.41%
0.10
81.03%
0.72
602.14%
price fair value
3.51
-
2.58
26.49%
1.90
26.44%
2.86
50.70%
3.08
7.47%
2.59
15.62%
receivables turnover
9.04
-
46.80
417.90%
54.18
15.77%
33.52
38.14%
61.13
82.39%
3.04
95.03%
return on assets
0.12
-
0.19
55.68%
0.03
86.05%
0.03
3.90%
0.00
90.68%
0.07
2,619.31%
return on capital employed
0.13
-
0.22
71.20%
0.08
64.56%
0.08
7.51%
0.06
24.26%
0.09
47.25%
return on equity
0.31
-
0.38
25.31%
0.06
85.42%
0.08
47.78%
0.01
90.82%
0.17
2,184.81%
total debt to capitalization
0.59
-
0.51
14.67%
0.37
26.75%
0.55
48.91%
0.56
1.29%
0.48
13.22%

All numbers in (except ratios and percentages)